Oncology Products

Bendamustine HCL

CAS No. : 3543-75-7
Non-Hodgkin lymphoma (NHL), blood cancer and multiple myeloma.

Cisplatin

CAS No. : 15663-27-1
Widely used chemotherapy; forms DNA adducts causing apoptosis in cancer cells.

Carboplatin

CAS No. : 41575-94-4
Platinum-based agent; forms DNA adducts causing crosslinking and apoptosis.

Oxaliplatin

CAS No. : 61825-94-3
Platinum-based chemotherapy primarily for colorectal cancer.

Imatinib Mesylate

CAS No. : 220127-57-1
Blood cancer and chronic myeloid leukaemia (CML); first-generation BCR-ABL TKI.

Dasatinib

CAS No. : 302962-49-8
Second-generation BCR-ABL/Src inhibitor for blood cancer and CML.

Nilotinib

CAS No. : 641571-10-0
Second-generation TKI for CML; effective in imatinibresistant cases.

Gefitinib

CAS No. : 184475-35-2
EGFR TKI for non-small cell lung cancer (NSCLC)

Lapatinib

CAS No. : 231277-92-2
Dual TKI (HER2/EGFR) for HER2-positive advanced breast cancer.

Lorlatinib

CAS No. : 1454846-35-5
Third-generation ALK/ROS1 inhibitor for NSCLC; active against resistant mutations.

Methotrexate

CAS No. : 59-05-2
Blocks DNA & RNA synthesis; used in various cancers and Rheumatoid Arthritis

5-Fluorouracil (5-FU)

CAS No. : 51-21-8
Antimetabolite for colorectal, breast, stomach and pancreatic cancers.

Cytarabine

CAS No. : 147-94-4
Treatment of acute myeloid leukaemia and lymphomas; interferes with DNA synthesis.

Paclitaxel

CAS No. : 33069-62-4
Breast cancer, ovarian cancer and lung cancer.

Docetaxel

CAS No. : 114977-28-5
Taxane for breast, lung and prostate cancers.

Letrozole

CAS No. : 112809-51-5
Aromatase inhibitor for breast cancer in postmenopausal women.

Anastrozole

CAS No. : 120511-73-1
Aromatase inhibitor for HRpositive breast cancer.

Fulvestrant

CAS No. : 129453-61-8
ER antagonist for HR-positive advanced breast cancer.

Olaparib

CAS No. : 763113-22-0
PARP inhibitor for BRCA-mutated ovarian and breast cancers.

Bortezomib

CAS No. : 179324-69-7
Proteasome inhibitor for multiple myeloma and mantle cell lymphoma